Nucleoside Reverse Transcriptase Inhibitors
- Name
- Nucleoside Reverse Transcriptase Inhibitors
- Accession Number
- DBCAT002755 (DBCAT001086)
- Description
Not Available
- Drugs
Drug Drug Description Abacavir An antiviral nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals for the treatment of HIV. Adefovir Not Annotated Dexelvucitabine Dexelvucitabine has been used in trials studying the treatment of HIV Infections and Human Immunodeficiency Virus. Didanosine A reverse transcriptase inhibitor used to treat HIV. Elvucitabine Investigated for use/treatment in hepatitis (viral, B) and HIV infection. Emtricitabine A nucleoside reverse transcriptase inhibitor used for the treatment and prophylaxis of HIV. Entecavir A nucleoside analogue used in the treatment of chronic hepatitis B for patients with active viral replication, histological evidence of active disease, or persistent elevations in liver transaminases. Lamivudine A reverse transcriptase inhibitor used to treat HIV and hepatitis B infections. Stavudine A dideoxynucleoside used in the treatment of HIV infection. Telbivudine A thymidine nucleoside analog used for the treatment of chronic hepatitis B with clinical evidence of viral replication or persistent elevations in serum aminotransferases (ALT or AST). Tenofovir A nucleotide analog indicated in the treatment of HIV infections. Zalcitabine A dideoxynucleoside used to treat HIV. Zidovudine A dideoxynucleoside used in the treatment of HIV infection. - Drugs & Drug Targets